Abstract
Four distinct dengue serotypes (DENV-1-4) are recognized, and Brazil is currently endemic for all. Infection by a serotype produces lasting immunity against reinfection by the same serotype, but cross-protection is temporary and partial, resulting in sequential infections. It occurs that heterotypic secondary infections appear to present a greater risk for signs of warning/severity. This …